Average Co-Inventor Count = 3.67
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ludwig Institute for Cancer Research Limited (19 from 525 patents)
2. Japanese Foundation for Cancer Research (5 from 55 patents)
3. Other (1 from 832,891 patents)
4. The University of Tokyo (1 from 1,287 patents)
5. Riken Corporation (1 from 855 patents)
6. Nippon Shinyaku Company, Ltd. (1 from 230 patents)
7. Curis, Inc. (1 from 141 patents)
8. Creative Biomolecules, Inc. (1 from 71 patents)
29 patents:
1. 10954216 - BMP-signal-inhibiting compound
2. 8080639 - Antibodies which bind specifically to activin receptor like kinase 3
3. 8012704 - Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
4. 7932351 - Activin receptor-like kinase-1 proteins having serine-threonine kinase domains
5. 7592428 - Antibodies which bind specifically to activin receptor like kinases
6. 7560532 - Smad6 and uses thereof
7. 7276525 - Osteogenesis-promotion enhancer and method of screening the same
8. 7067260 - Methods of identifying morphogen receptor-binding analogs
9. 6982319 - Antibodies which bind specifically to activin receptor-like kinases
10. 6964853 - Smad6 and uses thereof
11. 6692925 - Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
12. 6632618 - Morphogenic protein-specific cell surface receptors and uses therefor
13. 6534476 - Smad6 and uses thereof
14. 6331621 - Isolated nucleic acid molecules which encode activin-receptor like kinases, expression vectors and cells containing these
15. 6316217 - Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same